Kristin Anstatt
About Kristin Anstatt
Kristin Anstatt is the Associate Director of World Wide Patient Safety at Bristol Myers Squibb with over two decades of experience in global drug safety and risk management.
Current Position at Bristol Myers Squibb
Kristin Anstatt currently holds the position of Associate Director, WorldWide Patient Safety at Bristol Myers Squibb. In this role, she oversees various aspects of patient safety on a global scale, ensuring the efficacy and safety of pharmaceutical products. Her responsibilities include monitoring adverse effects, managing safety data, and implementing risk management strategies.
Previous Roles at Celgene
Before joining Bristol Myers Squibb, Kristin Anstatt served as Associate Director, Global Drug Safety & Risk Management at Celgene from 2018 to 2019. Prior to that, she worked as Senior Manager, Global Drug Safety & Risk Management at Celgene from 2016 to 2018. During her tenure at Celgene, she played a crucial role in managing safety profiles for various drugs, conducting risk assessments, and ensuring compliance with global safety regulations.
Experience at Merck
Kristin Anstatt worked at Merck as Associate Director, Global Safety from 2010 to 2016. Her responsibilities included overseeing the safety of pharmaceutical products throughout their lifecycle, from pre-market development to post-market surveillance. She transitioned to this role following the merger of Schering-Plough Research Institute with Merck in 2009. Her work at Merck emphasized her ability to manage complex safety issues and ensure regulatory compliance.
Early Career at Schering-Plough Research Institute
Kristin Anstatt began her career in the pharmaceutical industry at Schering-Plough Research Institute in 2001. She held various roles over a nine-year period, including Associate Manager, Associate, and Specialist in Global Safety. Her work primarily focused on drug safety monitoring and risk management, laying the foundation for her extensive experience in this field.
Extensive Experience in Drug Safety
With over two decades of experience, Kristin Anstatt has held multiple leadership roles in global safety across several major pharmaceutical companies. She has extensive expertise in managing drug safety for both pre-market and post-market products. Her career spans significant contributions to patient safety, drug risk management, and regulatory compliance, making her a seasoned professional in the field.